(Q39407209)

English

A long-term open-label study of oral almotriptan 12.5 mg for the treatment of acute migraine

scientific article published on January 2002

In more languages
default for all languages
No label defined

No description defined

Statements

A long-term open-label study of oral almotriptan 12.5 mg for the treatment of acute migraine (English)
Oral Almotriptan Study Group

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit